[go: up one dir, main page]

WO2008019785A3 - Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen - Google Patents

Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen Download PDF

Info

Publication number
WO2008019785A3
WO2008019785A3 PCT/EP2007/006992 EP2007006992W WO2008019785A3 WO 2008019785 A3 WO2008019785 A3 WO 2008019785A3 EP 2007006992 W EP2007006992 W EP 2007006992W WO 2008019785 A3 WO2008019785 A3 WO 2008019785A3
Authority
WO
WIPO (PCT)
Prior art keywords
triazines
transdermal application
coccidia infections
controlling
controlling coccidia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/006992
Other languages
English (en)
French (fr)
Other versions
WO2008019785A2 (de
Inventor
Iris Heep
Hans-Christian Mundt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Animal Health GmbH
Original Assignee
Bayer Animal Health GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12/377,156 priority Critical patent/US20100179151A1/en
Priority to AU2007286507A priority patent/AU2007286507B2/en
Priority to KR20097005122A priority patent/KR101489763B1/ko
Priority to UAA200902341A priority patent/UA98117C2/uk
Priority to MX2009001516A priority patent/MX2009001516A/es
Priority to RU2009109159/15A priority patent/RU2484825C9/ru
Priority to JP2009524103A priority patent/JP5340936B2/ja
Priority to NZ574885A priority patent/NZ574885A/en
Priority to BRPI0716404-1A2A priority patent/BRPI0716404A2/pt
Priority to EP07801543A priority patent/EP2054064A2/de
Application filed by Bayer Animal Health GmbH filed Critical Bayer Animal Health GmbH
Priority to CA2660762A priority patent/CA2660762C/en
Publication of WO2008019785A2 publication Critical patent/WO2008019785A2/de
Publication of WO2008019785A3 publication Critical patent/WO2008019785A3/de
Priority to IL196864A priority patent/IL196864A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die vorliegende Erfindung betrifft die transdermale Anwendung von Triazinen wie Toltrazuril oder Ponazuril zur Bekämpfung von Coccidien-Infektionen bei Tieren und Menschen.
PCT/EP2007/006992 2006-08-16 2007-08-08 Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen Ceased WO2008019785A2 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BRPI0716404-1A2A BRPI0716404A2 (pt) 2006-08-16 2007-08-08 aplicaÇço transdermal de triazinas para o combate de infecÇÕes por coccÍdeos
KR20097005122A KR101489763B1 (ko) 2006-08-16 2007-08-08 콕시디아 감염을 구제하기 위한 트리아진의 경피 적용
UAA200902341A UA98117C2 (uk) 2006-08-16 2007-08-08 Трансдермальне застосування триазинів для боротьби з інфекціями, викликаними кокцидіями
MX2009001516A MX2009001516A (es) 2006-08-16 2007-08-08 Aplicacion por via transdermica de triazinas para combatir infecciones por coccidios.
RU2009109159/15A RU2484825C9 (ru) 2006-08-16 2007-08-08 Трансдермальное применение триазинов для борьбы с инфекциями кокцидий
JP2009524103A JP5340936B2 (ja) 2006-08-16 2007-08-08 コクシジウム感染を制御するためのトリアジン類の経皮投与
NZ574885A NZ574885A (en) 2006-08-16 2007-08-08 Transdermal application of triazines for controlling coccidia infections
US12/377,156 US20100179151A1 (en) 2006-08-16 2007-08-08 Transdermal application of triazines for controlling infections with coccidia
AU2007286507A AU2007286507B2 (en) 2006-08-16 2007-08-08 Transdermal application of triazines for controlling coccidia infections
EP07801543A EP2054064A2 (de) 2006-08-16 2007-08-08 Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen
CA2660762A CA2660762C (en) 2006-08-16 2007-08-08 Transdermal application of triazines for controlling infections with coccidia
IL196864A IL196864A (en) 2006-08-16 2009-02-03 Administering triazines through the skin to control coccidia infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006038292A DE102006038292A1 (de) 2006-08-16 2006-08-16 Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102006038292.7 2006-08-16

Publications (2)

Publication Number Publication Date
WO2008019785A2 WO2008019785A2 (de) 2008-02-21
WO2008019785A3 true WO2008019785A3 (de) 2008-10-16

Family

ID=38670715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/006992 Ceased WO2008019785A2 (de) 2006-08-16 2007-08-08 Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen

Country Status (22)

Country Link
US (1) US20100179151A1 (de)
EP (1) EP2054064A2 (de)
JP (1) JP5340936B2 (de)
KR (1) KR101489763B1 (de)
CN (1) CN101505756A (de)
AU (1) AU2007286507B2 (de)
BR (1) BRPI0716404A2 (de)
CA (1) CA2660762C (de)
CO (1) CO6150133A2 (de)
CR (1) CR10618A (de)
DE (1) DE102006038292A1 (de)
GT (1) GT200900031A (de)
IL (1) IL196864A (de)
MX (1) MX2009001516A (de)
MY (1) MY151858A (de)
NI (1) NI200900017A (de)
NZ (1) NZ574885A (de)
RU (1) RU2484825C9 (de)
SV (1) SV2009003169A (de)
UA (1) UA98117C2 (de)
WO (1) WO2008019785A2 (de)
ZA (1) ZA200900913B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
US10568923B2 (en) 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
AU2013280331C1 (en) 2012-06-27 2018-06-21 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
EP2740470A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Behandlung von Coccidiosis mit intramuskulären Triazinzusammensetzungen
EP2740469A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Neue Behandlungen mit Triazinen
EP2740492A1 (de) * 2012-12-07 2014-06-11 Ceva Sante Animale Triazinformulierungen, einen weiteren Wirkstoff und Tensid(e) enthaltend
HUE061751T2 (hu) 2018-02-26 2023-08-28 AlzeCure Pharma AB Triazinszármazékok neurotrofinokhoz kapcsolódó betegségek kezelésére
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
NO344832B1 (no) * 2018-11-02 2020-05-18 Inakva As Sammensetning for anvendelse i hindring eller behandling av angrep eller infeksjon av parasitter på fisk

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000019964A2 (en) * 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
WO2002014288A1 (de) * 2000-08-17 2002-02-21 Bayer Aktiengesellschaft Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen
WO2004062673A1 (en) * 2003-01-16 2004-07-29 Janssen Pharmaceutica N.V. Anti-protozoal compositions comprising diclazuril
WO2005065713A2 (de) * 2004-01-10 2005-07-21 Bayer Healthcare Ag Arzneimittel zur topischen applikation bei tieren

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853388A (en) * 1987-05-15 1989-08-01 Pearlman Dale L Method for treating psoriasis with cytotoxic agents
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
CA2281755C (en) * 1997-02-24 2006-11-07 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
RU2174834C1 (ru) * 2000-05-18 2001-10-20 Открытое акционерное общество завод "Ветеринарные препараты" Препарат для профилактики и лечения кокцидиоза птиц
US20050058695A1 (en) * 2002-05-30 2005-03-17 Watson Pharmaccuticals, Inc. Norethindrone sustained release formulations and methods associated therewith

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000019964A2 (en) * 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
WO2002014288A1 (de) * 2000-08-17 2002-02-21 Bayer Aktiengesellschaft Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen
WO2004062673A1 (en) * 2003-01-16 2004-07-29 Janssen Pharmaceutica N.V. Anti-protozoal compositions comprising diclazuril
WO2005065713A2 (de) * 2004-01-10 2005-07-21 Bayer Healthcare Ag Arzneimittel zur topischen applikation bei tieren

Also Published As

Publication number Publication date
UA98117C2 (uk) 2012-04-25
MX2009001516A (es) 2009-02-18
JP5340936B2 (ja) 2013-11-13
BRPI0716404A2 (pt) 2013-09-17
DE102006038292A1 (de) 2008-02-21
CO6150133A2 (es) 2010-04-20
NI200900017A (es) 2010-04-19
AU2007286507A1 (en) 2008-02-21
SV2009003169A (es) 2009-07-28
RU2009109159A (ru) 2010-09-27
WO2008019785A2 (de) 2008-02-21
KR20090047520A (ko) 2009-05-12
KR101489763B1 (ko) 2015-02-05
US20100179151A1 (en) 2010-07-15
CA2660762A1 (en) 2008-02-21
CA2660762C (en) 2015-02-10
RU2484825C2 (ru) 2013-06-20
GT200900031A (es) 2010-10-04
JP2010500385A (ja) 2010-01-07
ZA200900913B (en) 2010-04-28
MY151858A (en) 2014-07-14
CR10618A (es) 2009-07-07
NZ574885A (en) 2012-03-30
IL196864A0 (en) 2009-11-18
CN101505756A (zh) 2009-08-12
RU2484825C9 (ru) 2013-11-20
EP2054064A2 (de) 2009-05-06
IL196864A (en) 2016-06-30
AU2007286507B2 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
WO2008019785A3 (de) Transdermale anwendung von triazinen zur bekämpfung von coccidien-infektionen
WO2008145281A8 (de) Formulierungen enthaltend triazinone und eisen
IL213489A0 (en) Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
WO2008051416A3 (en) Compounds that inhibit the activity of hsp90 for treating infections
IL180194A0 (en) Topical otic compositions and methods of topical treatment or prevention of otic infections
EP2586778A3 (de) Pyridazon-derivaten als glucan-synthase-hemmer
WO2008019115A3 (en) Formulations for parenteral delivery of compounds and uses thereof
WO2011047319A3 (en) Antimicrobial compounds and methods of making and using the same
WO2011047323A3 (en) Antimicrobial compounds and methods of making and using the same
WO2008115281A3 (en) Compounds for treating viral infections
WO2008085578A3 (en) Anti-microbial compositions and devices and methods of using the same
CL2007003332A1 (es) Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
WO2011047320A3 (en) Antimicrobial compounds and methods of making and using the same
WO2008144223A3 (en) Triazolyl aminopyrimidine compounds
WO2007089612A3 (en) Methods and compositions for treating and preventing bacterial infections
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
WO2009010787A3 (en) Stable pharmaceutical compositions comprising one or more hmg-coa reductase inhibitors
WO2007068750A3 (en) Immunoglobulins directed against nogo
WO2009011910A3 (en) Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
WO2007124382A3 (en) Inhaled imipenem
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
WO2007132355A3 (en) Compositions and methods for inhibiting viral adhesion
WO2006036817A3 (en) Fungal variants and uses thereof
WO2007096703A3 (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780030355.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07801543

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 196864

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/001516

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 09013880

Country of ref document: CO

Ref document number: 12009500296

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 574885

Country of ref document: NZ

Ref document number: 2660762

Country of ref document: CA

Ref document number: CR2009-010618

Country of ref document: CR

WWE Wipo information: entry into national phase

Ref document number: 2009524103

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2007801543

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12377156

Country of ref document: US

Ref document number: 2007801543

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007286507

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020097005122

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2009109159

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: A200902341

Country of ref document: UA

Ref document number: 1736/DELNP/2009

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2007286507

Country of ref document: AU

Date of ref document: 20070808

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0716404

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090213